Therefore, the modulation of proinflammatory cytokine secretion and altered Akt/mTOR signaling is an attractive avenue to discover therapies for skin cancer and inflammatory skin diseases, including eczema, seborrheic dermatitis, and psoriasis. The gene discussed is AKT1; the disease is skin cancer.